654.7K XNAS Volume
XNAS 20 Mar, 2025 2:10 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 2,040 | 158,084 (0%) | 0% | - | Common Stock | |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 2,893 | 2,415,415 (3%) | 0% | - | Common Stock | |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 148.38 per share. | 12 Mar 2025 | 13,935 | 2,365,715 (3%) | 0% | 148.4 | 2,067,696 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 147.64 per share. | 12 Mar 2025 | 29,967 | 2,379,650 (3%) | 0% | 147.6 | 4,424,187 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 146.58 per share. | 12 Mar 2025 | 4,798 | 2,409,617 (3%) | 0% | 146.6 | 703,296 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 145.37 per share. | 12 Mar 2025 | 1,000 | 2,414,415 (3%) | 0% | 145.4 | 145,369 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 149.00 per share. | 12 Mar 2025 | 300 | 2,365,415 (3%) | 0% | 149 | 44,700 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 411 | 261,200 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 2,032 | 72,661 (0%) | 0% | - | Common Stock | |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 145.86 per share. | 12 Mar 2025 | 1,014 | 12,690 (0%) | 0% | 145.9 | 147,907 | Common Stock |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 149.27 per share. | 12 Mar 2025 | 381 | 9,704 (0%) | 0% | 149.3 | 56,873 | Common Stock |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 148.71 per share. | 12 Mar 2025 | 1,682 | 10,085 (0%) | 0% | 148.7 | 250,127 | Common Stock |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 147.20 per share. | 12 Mar 2025 | 923 | 11,767 (0%) | 0% | 147.2 | 135,867 | Common Stock |
| Gail B. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.86 per share. | 12 Mar 2025 | 4,000 | 13,704 (0%) | 0% | 7.9 | 31,440 | Common Stock |
| Gail B. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2025 | 4,000 | 1,130 | - | - | Stock Option (right to buy) | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 6,702 | 210,056 (0%) | 0% | - | Common Stock | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 1,740 | 225,113 (0%) | 0% | - | Common Stock | |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 2,040 | 145,808 (0%) | 0% | - | Common Stock | |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 144.97 per share. | 05 Mar 2025 | 400 | 143,768 (0%) | 0% | 145.0 | 57,988 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 144.75 per share. | 05 Mar 2025 | 10,320 | 204,254 (0%) | 0% | 144.7 | 1,493,794 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 144.02 per share. | 05 Mar 2025 | 33,776 | 214,574 (0%) | 0% | 144.0 | 4,864,284 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 142.79 per share. | 05 Mar 2025 | 30,298 | 248,350 (0%) | 0% | 142.8 | 4,326,194 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 141.91 per share. | 05 Mar 2025 | 11,978 | 278,648 (0%) | 0% | 141.9 | 1,699,855 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 145.42 per share. | 05 Mar 2025 | 900 | 203,354 (0%) | 0% | 145.4 | 130,878 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 144.12 per share. | 05 Mar 2025 | 1,700 | 144,168 (0%) | 0% | 144.1 | 245,009 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 143.05 per share. | 05 Mar 2025 | 2,700 | 145,868 (0%) | 0% | 143.1 | 386,239 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 142.08 per share. | 05 Mar 2025 | 1,200 | 148,568 (0%) | 0% | 142.1 | 170,499 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 160.85 per share. | 26 Feb 2025 | 744 | 43,674 (0%) | 0% | 160.9 | 119,674 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 157.80 per share. | 26 Feb 2025 | 200 | 263,239 (0%) | 0% | 157.8 | 31,561 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 159.24 per share. | 26 Feb 2025 | 580 | 262,659 (0%) | 0% | 159.2 | 92,361 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 161.04 per share. | 26 Feb 2025 | 1,280 | 261,379 (0%) | 0% | 161.0 | 206,126 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 162.06 per share. | 26 Feb 2025 | 590 | 260,789 (0%) | 0% | 162.1 | 95,617 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 155.66 per share. | 26 Feb 2025 | 64 | 44,718 (0%) | 0% | 155.7 | 9,962 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 158.77 per share. | 26 Feb 2025 | 296 | 44,422 (0%) | 0% | 158.8 | 46,995 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 160.76 per share. | 26 Feb 2025 | 704 | 43,718 (0%) | 0% | 160.8 | 113,173 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 161.58 per share. | 26 Feb 2025 | 336 | 43,382 (0%) | 0% | 161.6 | 54,290 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 162.64 per share. | 26 Feb 2025 | 100 | 43,282 (0%) | 0% | 162.6 | 16,264 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 155.67 per share. | 26 Feb 2025 | 72 | 44,710 (0%) | 0% | 155.7 | 11,208 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 158.88 per share. | 26 Feb 2025 | 292 | 44,418 (0%) | 0% | 158.9 | 46,394 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 161.64 per share. | 26 Feb 2025 | 296 | 43,378 (0%) | 0% | 161.6 | 47,846 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 162.64 per share. | 26 Feb 2025 | 96 | 43,282 (0%) | 0% | 162.6 | 15,613 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 155.82 per share. | 26 Feb 2025 | 50 | 263,439 (0%) | 0% | 155.8 | 7,791 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 1,675 | 156,707 (0%) | 0% | - | Common Stock | |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 177.77 per share. | 05 Feb 2025 | 663 | 156,044 (0%) | 0% | 177.8 | 117,862 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 1,675 | 149,878 (0%) | 0% | - | Common Stock | |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 1,522 | 151,400 (0%) | 0% | - | Common Stock | |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 177.77 per share. | 05 Feb 2025 | 1,632 | 149,768 (0%) | 0% | 177.8 | 290,121 | Common Stock |
| Roy D. Baynes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 92 | 15,899 (0%) | 0% | - | Common Stock | |
| Herm Rosenman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 133 | 65,898 (0%) | 0% | - | Common Stock | |
| James I. Healy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 114 | 46,118 (0%) | 0% | - | Common Stock | |
| Roelof Frederik Botha | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 151 | 3,918 (0%) | 0% | - | Common Stock | |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 29,345 | 2,412,522 (3%) | 0% | - | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 3,549 | 263,489 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 178.19 per share. | 31 Jan 2025 | 1,500 | 70,629 (0%) | 0% | 178.2 | 267,284 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 173.05 per share. | 31 Jan 2025 | 400 | 114,131 (0%) | 0% | 173.1 | 69,220 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 176.61 per share. | 31 Jan 2025 | 17,140 | 93,491 (0%) | 0% | 176.6 | 3,027,114 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 177.25 per share. | 31 Jan 2025 | 21,362 | 72,129 (0%) | 0% | 177.2 | 3,786,363 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 175.39 per share. | 31 Jan 2025 | 3,500 | 110,631 (0%) | 0% | 175.4 | 613,881 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 12,720 | 114,531 (0%) | 0% | - | Common Stock | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 36,682 | 290,626 (0%) | 0% | - | Common Stock | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 10,353 | 223,373 (0%) | 0% | - | Common Stock | |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 12,720 | 148,203 (0%) | 0% | - | Common Stock | |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 11,832 | 155,032 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 165.87 per share. | 29 Jan 2025 | 3,115 | 103,699 (0%) | 0% | 165.9 | 516,681 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 167.33 per share. | 29 Jan 2025 | 3 | 263,821 (0%) | 0% | 167.3 | 502 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 165.87 per share. | 29 Jan 2025 | 3,805 | 263,824 (0%) | 0% | 165.9 | 631,130 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 167.43 per share. | 29 Jan 2025 | 7 | 253,944 (0%) | 0% | 167.4 | 1,172 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 165.87 per share. | 29 Jan 2025 | 9,870 | 253,951 (0%) | 0% | 165.9 | 1,637,124 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 165.87 per share. | 29 Jan 2025 | 3,730 | 213,022 (0%) | 0% | 165.9 | 618,690 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 167.00 per share. | 29 Jan 2025 | 2 | 213,020 (0%) | 0% | 167 | 334 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 165.87 per share. | 29 Jan 2025 | 1,041 | 216,752 (0%) | 0% | 165.9 | 172,669 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 165.87 per share. | 29 Jan 2025 | 4,020 | 135,486 (0%) | 0% | 165.9 | 666,792 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 167.33 per share. | 29 Jan 2025 | 3 | 135,483 (0%) | 0% | 167.3 | 502 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 165.87 per share. | 29 Jan 2025 | 1,178 | 139,056 (0%) | 0% | 165.9 | 195,393 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 165.87 per share. | 29 Jan 2025 | 3,115 | 143,202 (0%) | 0% | 165.9 | 516,681 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 167.50 per share. | 29 Jan 2025 | 2 | 143,200 (0%) | 0% | 167.5 | 335 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 165.87 per share. | 29 Jan 2025 | 913 | 146,317 (0%) | 0% | 165.9 | 151,438 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 176.60 per share. | 29 Jan 2025 | 1,886 | 101,811 (0%) | 0% | 176.6 | 333,068 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 165.87 per share. | 29 Jan 2025 | 5,999 | 2,383,181 (3%) | 0% | 165.9 | 995,046 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 167.25 per share. | 29 Jan 2025 | 4 | 2,383,177 (3%) | 0% | 167.3 | 669 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 176.60 per share. | 29 Jan 2025 | 163 | 259,940 (0%) | 0% | 176.6 | 28,786 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 167.00 per share. | 29 Jan 2025 | 1 | 260,103 (0%) | 0% | 167 | 167 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 165.87 per share. | 29 Jan 2025 | 1,053 | 260,104 (0%) | 0% | 165.9 | 174,660 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 167.00 per share. | 29 Jan 2025 | 2 | 103,697 (0%) | 0% | 167 | 334 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 167.00 per share. | 29 Jan 2025 | 1 | 106,814 (0%) | 0% | 167 | 167 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 165.87 per share. | 29 Jan 2025 | 1,217 | 106,815 (0%) | 0% | 165.9 | 201,862 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Gift of securities by or to the insider at price $ 0.00 per share. | 27 Jan 2025 | 588 | 261,157 (0%) | 0% | 0 | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 161.87 per share. | 27 Jan 2025 | 1,442 | 108,032 (0%) | 0% | 161.9 | 233,417 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 171.80 per share. | 22 Jan 2025 | 687 | 109,733 (0%) | 0% | 171.8 | 118,027 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jan 2025 | 1,250 | 110,915 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 171.09 per share. | 22 Jan 2025 | 495 | 110,420 (0%) | 0% | 171.1 | 84,690 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jan 2025 | 1,250 | 3,750 | - | - | Restricted Stock Unit | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 172.44 per share. | 22 Jan 2025 | 259 | 109,474 (0%) | 0% | 172.4 | 44,662 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 171.95 per share. | 22 Jan 2025 | 62 | 140,684 (0%) | 0% | 172.0 | 10,661 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 164.95 per share. | 22 Jan 2025 | 24,799 | 140,746 (0%) | 0% | 164.9 | 4,090,565 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 171.96 per share. | 22 Jan 2025 | 53 | 147,230 (0%) | 0% | 172.0 | 9,114 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 164.95 per share. | 22 Jan 2025 | 21,175 | 147,283 (0%) | 0% | 164.9 | 3,492,791 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 191 | 761 | - | - | Restricted Stock Unit | |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 191 | 262,572 (0%) | 0% | - | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 144 | 262,716 (0%) | 0% | - | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 164.95 per share. | 20 Jan 2025 | 964 | 261,752 (0%) | 0% | 164.9 | 159,011 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 171.86 per share. | 20 Jan 2025 | 7 | 261,745 (0%) | 0% | 171.9 | 1,203 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 144 | 0 | - | - | Restricted Stock Unit | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 1,145 | 0 | - | - | Restricted Stock Unit | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 1,522 | 134,451 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 1,145 | 135,596 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 164.95 per share. | 20 Jan 2025 | 25,867 | 109,729 (0%) | 0% | 164.9 | 4,266,731 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 171.95 per share. | 20 Jan 2025 | 64 | 109,665 (0%) | 0% | 172.0 | 11,005 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 1,522 | 6,087 | - | - | Restricted Stock Unit | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 1,775 | 0 | - | - | Restricted Stock Unit | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 3,386 | 13,544 | - | - | Restricted Stock Unit | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 171.97 per share. | 20 Jan 2025 | 194 | 267,629 (0%) | 0% | 172.0 | 33,362 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 164.95 per share. | 20 Jan 2025 | 78,359 | 267,823 (0%) | 0% | 164.9 | 12,925,223 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 1,775 | 346,182 (0%) | 0% | - | Common Stock | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 3,386 | 344,407 (0%) | 0% | - | Common Stock | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 644 | 0 | - | - | Restricted Stock Unit | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 164.95 per share. | 20 Jan 2025 | 21,985 | 217,847 (0%) | 0% | 164.9 | 3,626,399 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 171.94 per share. | 20 Jan 2025 | 54 | 217,793 (0%) | 0% | 171.9 | 9,285 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 644 | 239,832 (0%) | 0% | - | Common Stock | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 856 | 239,188 (0%) | 0% | - | Common Stock | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 856 | 3,424 | - | - | Restricted Stock Unit | |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2025 | 3,043 | 257,415 (0%) | 0% | - | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2025 | 4,966 | 262,381 (0%) | 0% | - | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2025 | 3,043 | 0 | - | - | Restricted Stock Unit | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2025 | 24,348 | 0 | - | - | Restricted Stock Unit | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2025 | 24,348 | 93,199 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2025 | 39,730 | 132,929 (0%) | 0% | - | Common Stock | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2025 | 101,812 | 341,021 (0%) | 0% | - | Common Stock | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2025 | 54,175 | 0 | - | - | Restricted Stock Unit | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2025 | 54,175 | 239,209 (0%) | 0% | - | Common Stock | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2025 | 13,696 | 0 | - | - | Restricted Stock Unit | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2025 | 24,832 | 238,332 (0%) | 0% | - | Common Stock | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2025 | 13,696 | 213,500 (0%) | 0% | - | Common Stock | |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2025 | 9,130 | 126,127 (0%) | 0% | - | Common Stock | |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2025 | 29,798 | 155,925 (0%) | 0% | - | Common Stock | |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2025 | 9,620 | 165,545 (0%) | 0% | - | Common Stock | |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2025 | 10,822 | 168,458 (0%) | 0% | - | Common Stock | |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2025 | 13,696 | 127,838 (0%) | 0% | - | Common Stock | |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2025 | 29,798 | 157,636 (0%) | 0% | - | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 158.71 per share. | 02 Jan 2025 | 1,230 | 255,842 (0%) | 0% | 158.7 | 195,212 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 159.65 per share. | 02 Jan 2025 | 900 | 254,942 (0%) | 0% | 159.7 | 143,688 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 160.67 per share. | 02 Jan 2025 | 570 | 254,372 (0%) | 0% | 160.7 | 91,581 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 158.73 per share. | 02 Jan 2025 | 641 | 45,641 (0%) | 0% | 158.7 | 101,749 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 159.69 per share. | 02 Jan 2025 | 555 | 45,086 (0%) | 0% | 159.7 | 88,628 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 160.68 per share. | 02 Jan 2025 | 304 | 44,782 (0%) | 0% | 160.7 | 48,848 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 158.73 per share. | 02 Jan 2025 | 480 | 45,802 (0%) | 0% | 158.7 | 76,192 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 159.76 per share. | 02 Jan 2025 | 732 | 45,070 (0%) | 0% | 159.8 | 116,947 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 160.70 per share. | 02 Jan 2025 | 288 | 44,782 (0%) | 0% | 160.7 | 46,281 | Common Stock |
| Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 159.60 per share. | 20 Dec 2024 | 668 | 114,142 (0%) | 0% | 159.6 | 106,616 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 159.60 per share. | 20 Dec 2024 | 2,423 | 116,997 (0%) | 0% | 159.6 | 386,721 | Common Stock |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2024 | 1,675 | 116,381 (0%) | 0% | - | Common Stock | |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2024 | 1,675 | 114,811 (0%) | 0% | - | Common Stock | |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 158.00 per share. | 20 Dec 2024 | 1 | 114,810 (0%) | 0% | 158 | 158 | Common Stock |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2024 | 3,044 | 119,425 (0%) | 0% | - | Common Stock | |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 158.33 per share. | 20 Dec 2024 | 3 | 119,420 (0%) | 0% | 158.3 | 475 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 158.00 per share. | 20 Dec 2024 | 2 | 119,423 (0%) | 0% | 158 | 316 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Dec 2024 | 81 | 114,706 (0%) | 0% | 0 | Common Stock | |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Dec 2024 | 125 | 114,787 (0%) | 0% | 0 | Common Stock | |
| Sheena Jonathan | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 167.07 per share. | 18 Dec 2024 | 852 | 46,778 (0%) | 0% | 167.1 | 142,347 | Common Srock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 168.15 per share. | 18 Dec 2024 | 537 | 257,072 (0%) | 0% | 168.1 | 90,294 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 167.25 per share. | 18 Dec 2024 | 1,825 | 257,609 (0%) | 0% | 167.2 | 305,231 | Common Stock |
| Sheena Jonathan | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 166.01 per share. | 18 Dec 2024 | 152 | 47,630 (0%) | 0% | 166.0 | 25,233 | Common Stock |
| Sheena Jonathan | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 165.97 per share. | 18 Dec 2024 | 338 | 259,434 (0%) | 0% | 166.0 | 56,099 | Common Stock |
| Sheena Jonathan | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 168.02 per share. | 18 Dec 2024 | 496 | 46,282 (0%) | 0% | 168.0 | 83,339 | Common Stock |
| Sheena Jonathan | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 166.18 per share. | 18 Dec 2024 | 238 | 47,544 (0%) | 0% | 166.2 | 39,550 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 167.18 per share. | 18 Dec 2024 | 959 | 46,585 (0%) | 0% | 167.2 | 160,325 | Common Stock |
| Sheena Jonathan | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 168.04 per share. | 18 Dec 2024 | 303 | 46,282 (0%) | 0% | 168.0 | 50,917 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 167.39 per share. | 13 Dec 2024 | 4,927 | 2,394,480 (3%) | 0% | 167.4 | 824,722 | Common Stock |
| Rabinowitz Matthew | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 164.61 per share. | 13 Dec 2024 | 28,681 | 2,520,499 (3%) | 0% | 164.6 | 4,721,211 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 165.45 per share. | 13 Dec 2024 | 75,323 | 2,445,176 (3%) | 0% | 165.4 | 12,462,190 | Common Stock |
| Rabinowitz Matthew | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 166.45 per share. | 13 Dec 2024 | 45,769 | 2,399,407 (3%) | 0% | 166.5 | 7,618,346 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 168.35 per share. | 13 Dec 2024 | 5,300 | 2,389,180 (3%) | 0% | 168.4 | 892,280 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.40 per share. | 05 Dec 2024 | 68,496 | 2,549,180 (3%) | 0% | 5.4 | 369,556 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Dec 2024 | 68,496 | 0 | - | - | Stock Option (right to buy) | |
| Roelof Frederik Botha | Director | Sale of securities on an exchange or to another person at price $ 169.78 per share. | 02 Dec 2024 | 40,171 | 1,236,006 (1%) | 0% | 169.8 | 6,820,228 | Common Stock |
| Roelof Frederik Botha | Director | Sale of securities on an exchange or to another person at price $ 168.73 per share. | 02 Dec 2024 | 16,853 | 1,276,177 (1%) | 0% | 168.7 | 2,843,578 | Common Stock |
| Roelof Frederik Botha | Director | Sale of securities on an exchange or to another person at price $ 166.88 per share. | 02 Dec 2024 | 8,783 | 1,303,477 (1%) | 0% | 166.9 | 1,465,667 | Common Stock |
| Roelof Frederik Botha | Director | Sale of securities on an exchange or to another person at price $ 167.59 per share. | 02 Dec 2024 | 10,447 | 1,293,030 (1%) | 0% | 167.6 | 1,750,792 | Common Stock |
| Roelof Frederik Botha | Director | Sale of securities on an exchange or to another person at price $ 170.54 per share. | 02 Dec 2024 | 11,219 | 1,224,787 (1%) | 0% | 170.5 | 1,913,298 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 165.55 per share. | 25 Nov 2024 | 400 | 84,000 (0%) | 0% | 165.6 | 66,220 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 163.25 per share. | 25 Nov 2024 | 660 | 85,340 (0%) | 0% | 163.2 | 107,744 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 164.24 per share. | 25 Nov 2024 | 940 | 84,400 (0%) | 0% | 164.2 | 154,384 | Common Stock |
| Rabinowitz Matthew | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 169.94 per share. | 25 Nov 2024 | 311 | 86,000 (0%) | 0% | 169.9 | 52,851 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 167.89 per share. | 25 Nov 2024 | 1,089 | 86,911 (0%) | 0% | 167.9 | 182,831 | Common Stock |
| Rabinowitz Matthew | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 168.91 per share. | 25 Nov 2024 | 600 | 86,311 (0%) | 0% | 168.9 | 101,346 | Common Stock |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 159.83 per share. | 19 Nov 2024 | 7,582 | 11,804 (0%) | 0% | 159.8 | 1,211,842 | Common Stock |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 160.52 per share. | 19 Nov 2024 | 2,100 | 9,704 (0%) | 0% | 160.5 | 337,089 | Common Stock |
| Roy D. Baynes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.42 per share. | 15 Nov 2024 | 15,230 | 53,037 (0%) | 0% | 24.4 | 371,917 | Common Stock |
| Roy D. Baynes | Director | Sale of securities on an exchange or to another person at price $ 148.74 per share. | 15 Nov 2024 | 2,106 | 17,790 (0%) | 0% | 148.7 | 313,250 | Common Stock |
| Roy D. Baynes | Director | Sale of securities on an exchange or to another person at price $ 147.31 per share. | 15 Nov 2024 | 9,467 | 19,896 (0%) | 0% | 147.3 | 1,394,620 | Common Stock |
| Roy D. Baynes | Director | Sale of securities on an exchange or to another person at price $ 146.25 per share. | 15 Nov 2024 | 1,770 | 29,363 (0%) | 0% | 146.3 | 258,871 | Common Stock |
| Roy D. Baynes | Director | Sale of securities on an exchange or to another person at price $ 145.21 per share. | 15 Nov 2024 | 16,404 | 31,133 (0%) | 0% | 145.2 | 2,381,997 | Common Stock |
| Roy D. Baynes | Director | Sale of securities on an exchange or to another person at price $ 144.26 per share. | 15 Nov 2024 | 5,500 | 47,537 (0%) | 0% | 144.3 | 793,419 | Common Stock |
| Roy D. Baynes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.83 per share. | 15 Nov 2024 | 22,000 | 37,807 (0%) | 0% | 22.8 | 502,260 | Common Stock |
| Roy D. Baynes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 15,230 | 0 | - | - | Stock Option (right to buy) | |
| Roy D. Baynes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 22,000 | 0 | - | - | Stock Option (right to buy) | |
| Roy D. Baynes | Director | Sale of securities on an exchange or to another person at price $ 149.98 per share. | 15 Nov 2024 | 1,983 | 15,807 (0%) | 0% | 150.0 | 297,408 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 150.00 per share. | 15 Nov 2024 | 440 | 185,034 (0%) | 0% | 150 | 66,000 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 148.92 per share. | 15 Nov 2024 | 351 | 185,474 (0%) | 0% | 148.9 | 52,272 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 147.83 per share. | 15 Nov 2024 | 1,052 | 185,825 (0%) | 0% | 147.8 | 155,517 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 146.35 per share. | 15 Nov 2024 | 100 | 186,877 (0%) | 0% | 146.4 | 14,635 | Common Stok |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 145.29 per share. | 15 Nov 2024 | 1,800 | 186,977 (0%) | 0% | 145.3 | 261,515 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 144.44 per share. | 15 Nov 2024 | 985 | 188,777 (0%) | 0% | 144.4 | 142,270 | Common Stock |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 157.86 per share. | 14 Nov 2024 | 791 | 20,307 (0%) | 0% | 157.9 | 124,865 | Common Stock |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 162.04 per share. | 14 Nov 2024 | 200 | 19,386 (0%) | 0% | 162.0 | 32,408 | Common Stock |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 159.85 per share. | 14 Nov 2024 | 371 | 19,586 (0%) | 0% | 159.9 | 59,306 | Common Stock |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 159.19 per share. | 14 Nov 2024 | 350 | 19,957 (0%) | 0% | 159.2 | 55,716 | Common Stock |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 156.75 per share. | 14 Nov 2024 | 500 | 21,098 (0%) | 0% | 156.8 | 78,377 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 153.52 per share. | 13 Nov 2024 | 64 | 51,857 (0%) | 0% | 153.5 | 9,825 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 160.02 per share. | 13 Nov 2024 | 4,075 | 47,782 (0%) | 0% | 160.0 | 652,065 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 154.40 per share. | 13 Nov 2024 | 458 | 51,857 (0%) | 0% | 154.4 | 70,715 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 152.93 per share. | 13 Nov 2024 | 3,617 | 52,315 (0%) | 0% | 152.9 | 553,134 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 160.02 per share. | 13 Nov 2024 | 4,075 | 47,782 (0%) | 0% | 160.0 | 652,083 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 152.78 per share. | 13 Nov 2024 | 4,011 | 51,921 (0%) | 0% | 152.8 | 612,806 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 154.11 per share. | 13 Nov 2024 | 11,974 | 259,772 (0%) | 0% | 154.1 | 1,845,296 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 152.69 per share. | 13 Nov 2024 | 8,026 | 271,746 (0%) | 0% | 152.7 | 1,225,472 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2024 | 10,000 | 68,496 | - | - | Stock Option (right to buy) | |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2024 | 130,000 | 78,496 | - | - | Stock Option (right to buy) | |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.40 per share. | 11 Nov 2024 | 130,000 | 2,470,684 (3%) | 0% | 5.4 | 701,389 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.40 per share. | 11 Nov 2024 | 10,000 | 2,480,684 (3%) | 0% | 5.4 | 53,953 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 129.78 per share. | 08 Nov 2024 | 360 | 282,112 (0%) | 0% | 129.8 | 46,720 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 130.40 per share. | 08 Nov 2024 | 736 | 56,696 (0%) | 0% | 130.4 | 95,971 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 131.14 per share. | 08 Nov 2024 | 764 | 55,932 (0%) | 0% | 131.1 | 100,189 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 130.47 per share. | 08 Nov 2024 | 998 | 56,434 (0%) | 0% | 130.5 | 130,210 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 131.24 per share. | 08 Nov 2024 | 412 | 56,022 (0%) | 0% | 131.2 | 54,070 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 131.84 per share. | 08 Nov 2024 | 90 | 55,932 (0%) | 0% | 131.8 | 11,866 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 131.85 per share. | 08 Nov 2024 | 169 | 279,772 (0%) | 0% | 131.9 | 22,283 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 130.89 per share. | 08 Nov 2024 | 2,171 | 279,941 (0%) | 0% | 130.9 | 284,162 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 126.45 per share. | 31 Oct 2024 | 1,866 | 68,851 (0%) | 0% | 126.5 | 235,956 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 118.21 per share. | 28 Oct 2024 | 1,238 | 71,471 (0%) | 0% | 118.2 | 146,345 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 119.93 per share. | 28 Oct 2024 | 754 | 70,717 (0%) | 0% | 119.9 | 90,427 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 118.21 per share. | 28 Oct 2024 | 3,960 | 189,762 (0%) | 0% | 118.2 | 468,114 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 118.21 per share. | 28 Oct 2024 | 1,057 | 206,027 (0%) | 0% | 118.2 | 124,948 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 118.21 per share. | 28 Oct 2024 | 1,196 | 110,695 (0%) | 0% | 118.2 | 141,380 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 118.21 per share. | 28 Oct 2024 | 929 | 113,136 (0%) | 0% | 118.2 | 109,818 | Common Stock |
| Herm Rosenman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Oct 2024 | 178 | 65,765 (0%) | 0% | - | Common Stock | |
| James I. Healy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Oct 2024 | 153 | 46,004 (0%) | 0% | - | Common Stock | |
| Roelof Frederik Botha | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Oct 2024 | 203 | 3,767 (0%) | 0% | - | Common Stock | |
| Roy D. Baynes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Oct 2024 | 124 | 15,807 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 119.19 per share. | 24 Oct 2024 | 914 | 73,400 (0%) | 0% | 119.2 | 108,940 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 118.81 per share. | 24 Oct 2024 | 691 | 72,709 (0%) | 0% | 118.8 | 82,098 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 119.09 per share. | 22 Oct 2024 | 496 | 74,314 (0%) | 0% | 119.1 | 59,068 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Oct 2024 | 1,250 | 5,000 | - | - | Restricted Stock Unit | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Oct 2024 | 1,250 | 74,810 (0%) | 0% | - | Common Stock | |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 120.76 per share. | 21 Oct 2024 | 294 | 112,147 (0%) | 0% | 120.8 | 35,503 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 120.07 per share. | 21 Oct 2024 | 256 | 111,891 (0%) | 0% | 120.1 | 30,738 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 120.76 per share. | 21 Oct 2024 | 342 | 114,264 (0%) | 0% | 120.8 | 41,299 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 120.07 per share. | 21 Oct 2024 | 199 | 114,065 (0%) | 0% | 120.1 | 23,894 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2024 | 190 | 282,231 (0%) | 0% | - | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2024 | 143 | 144 | - | - | Restricted Stock Unit | |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2024 | 190 | 952 | - | - | Restricted Stock Unit | |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2024 | 143 | 282,374 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2024 | 1,522 | 73,477 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2024 | 1,145 | 1,145 | - | - | Restricted Stock Unit | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2024 | 1,522 | 7,609 | - | - | Restricted Stock Unit | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 120.07 per share. | 20 Oct 2024 | 454 | 73,560 (0%) | 0% | 120.1 | 54,512 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 120.76 per share. | 20 Oct 2024 | 608 | 74,014 (0%) | 0% | 120.8 | 73,420 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2024 | 1,145 | 74,622 (0%) | 0% | - | Common Stock | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2024 | 1,775 | 196,324 (0%) | 0% | - | Common Stock | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 120.76 per share. | 20 Oct 2024 | 1,709 | 194,615 (0%) | 0% | 120.8 | 206,375 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 120.07 per share. | 20 Oct 2024 | 893 | 193,722 (0%) | 0% | 120.1 | 107,223 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2024 | 3,386 | 16,930 | - | - | Restricted Stock Unit | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2024 | 1,775 | 1,775 | - | - | Restricted Stock Unit | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2024 | 3,386 | 194,549 (0%) | 0% | - | Common Stock | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 120.76 per share. | 20 Oct 2024 | 467 | 207,433 (0%) | 0% | 120.8 | 56,394 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2024 | 644 | 644 | - | - | Restricted Stock Unit | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2024 | 856 | 4,280 | - | - | Restricted Stock Unit | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 120.07 per share. | 20 Oct 2024 | 349 | 207,084 (0%) | 0% | 120.1 | 41,904 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2024 | 644 | 207,900 (0%) | 0% | - | Common Stock | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2024 | 856 | 207,256 (0%) | 0% | - | Common Stock | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 130.40 per share. | 15 Oct 2024 | 4,523 | 191,163 (0%) | 0% | 130.4 | 589,797 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 124.82 per share. | 01 Oct 2024 | 876 | 283,865 (0%) | 0% | 124.8 | 109,346 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 125.95 per share. | 01 Oct 2024 | 1,025 | 57,432 (0%) | 0% | 126.0 | 129,100 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 124.89 per share. | 01 Oct 2024 | 475 | 58,457 (0%) | 0% | 124.9 | 59,322 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 126.27 per share. | 01 Oct 2024 | 729 | 57,432 (0%) | 0% | 126.3 | 92,051 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 125.23 per share. | 01 Oct 2024 | 771 | 58,161 (0%) | 0% | 125.2 | 96,550 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 126.42 per share. | 01 Oct 2024 | 427 | 282,041 (0%) | 0% | 126.4 | 53,982 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 125.83 per share. | 01 Oct 2024 | 1,397 | 282,468 (0%) | 0% | 125.8 | 175,785 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 127.38 per share. | 18 Sep 2024 | 1,922 | 285,519 (0%) | 0% | 127.4 | 244,822 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 127.38 per share. | 18 Sep 2024 | 6,404 | 62,178 (0%) | 0% | 127.4 | 815,728 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 128.06 per share. | 18 Sep 2024 | 3,246 | 58,932 (0%) | 0% | 128.1 | 415,678 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 128.07 per share. | 18 Sep 2024 | 3,066 | 58,932 (0%) | 0% | 128.1 | 392,677 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 127.39 per share. | 18 Sep 2024 | 6,584 | 61,998 (0%) | 0% | 127.4 | 838,704 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 128.06 per share. | 18 Sep 2024 | 778 | 284,741 (0%) | 0% | 128.1 | 99,628 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 126.66 per share. | 16 Sep 2024 | 1,042 | 199,668 (0%) | 0% | 126.7 | 131,984 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 130.93 per share. | 16 Sep 2024 | 500 | 195,686 (0%) | 0% | 130.9 | 65,466 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 129.90 per share. | 16 Sep 2024 | 598 | 196,186 (0%) | 0% | 129.9 | 77,678 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 128.87 per share. | 16 Sep 2024 | 1,626 | 196,784 (0%) | 0% | 128.9 | 209,539 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 127.83 per share. | 16 Sep 2024 | 1,258 | 198,410 (0%) | 0% | 127.8 | 160,807 | Common Stock |
| Rowan E. Chapman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2024 | 2,614 | 0 | - | - | Stock Option (right to buy) | |
| Rowan E. Chapman | Director | Sale of securities on an exchange or to another person at price $ 127.68 per share. | 13 Sep 2024 | 2,614 | 7,969 (0%) | 0% | 127.7 | 333,756 | Common Stock |
| Rowan E. Chapman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 94.14 per share. | 13 Sep 2024 | 2,614 | 10,583 (0%) | 0% | 94.1 | 246,082 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 121.01 per share. | 15 Aug 2024 | 12,000 | 287,441 (0%) | 0% | 121.0 | 1,452,125 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 120.00 per share. | 15 Aug 2024 | 577 | 200,710 (0%) | 0% | 120 | 69,240 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 118.79 per share. | 15 Aug 2024 | 5,006 | 201,287 (0%) | 0% | 118.8 | 594,655 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 114.11 per share. | 12 Aug 2024 | 781 | 300,141 (0%) | 0% | 114.1 | 89,119 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 112.80 per share. | 12 Aug 2024 | 1,219 | 300,922 (0%) | 0% | 112.8 | 137,507 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 115.70 per share. | 12 Aug 2024 | 220 | 299,441 (0%) | 0% | 115.7 | 25,454 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 115.07 per share. | 12 Aug 2024 | 480 | 299,661 (0%) | 0% | 115.1 | 55,234 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 116.67 per share. | 12 Aug 2024 | 3,956 | 114,606 (0%) | 0% | 116.7 | 461,547 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2024 | 10,000 | 118,562 (0%) | 0% | - | Common Stock | |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.40 per share. | 08 Aug 2024 | 190,000 | 1,480,648 (1%) | 0% | 5.4 | 1,025,107 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2024 | 190,000 | 208,496 | - | - | Stock Option (right to buy) | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 99.65 per share. | 29 Jul 2024 | 1,866 | 71,955 (0%) | 0% | 99.7 | 185,947 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 102.77 per share. | 29 Jul 2024 | 1,238 | 73,821 (0%) | 0% | 102.8 | 127,224 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 102.77 per share. | 29 Jul 2024 | 4,084 | 206,293 (0%) | 0% | 102.8 | 419,695 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 102.77 per share. | 29 Jul 2024 | 1,057 | 206,400 (0%) | 0% | 102.8 | 108,623 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 102.77 per share. | 29 Jul 2024 | 1,196 | 112,441 (0%) | 0% | 102.8 | 122,908 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.40 per share. | 29 Jul 2024 | 100 | 108,562 (0%) | 0% | 5.4 | 540 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jul 2024 | 100 | 0 | - | - | Stock Option (right to buy) | |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 102.77 per share. | 29 Jul 2024 | 929 | 108,462 (0%) | 0% | 102.8 | 95,469 | Common Stock |
| Herm Rosenman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2024 | 206 | 65,587 (0%) | 0% | - | Common Stock | |
| James I. Healy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2024 | 177 | 45,851 (0%) | 0% | - | Common Stock | |
| Roelof Frederik Botha | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2024 | 234 | 3,564 (0%) | 0% | - | Common Stock | |
| Roy D. Baynes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2024 | 143 | 15,683 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 102.18 per share. | 24 Jul 2024 | 751 | 75,059 (0%) | 0% | 102.2 | 76,737 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 105.53 per share. | 24 Jul 2024 | 918 | 76,500 (0%) | 0% | 105.5 | 96,877 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 105.29 per share. | 24 Jul 2024 | 690 | 75,810 (0%) | 0% | 105.3 | 72,650 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 105.16 per share. | 22 Jul 2024 | 549 | 113,637 (0%) | 0% | 105.2 | 57,733 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 105.16 per share. | 22 Jul 2024 | 549 | 109,391 (0%) | 0% | 105.2 | 57,732 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jul 2024 | 190 | 301,998 (0%) | 0% | - | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jul 2024 | 143 | 287 | - | - | Restricted Stock Unit | |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jul 2024 | 190 | 1,142 | - | - | Restricted Stock Unit | |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jul 2024 | 143 | 302,141 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 105.16 per share. | 20 Jul 2024 | 1,059 | 77,917 (0%) | 0% | 105.2 | 111,364 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jul 2024 | 1,250 | 78,976 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jul 2024 | 1,145 | 77,726 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jul 2024 | 1,522 | 76,581 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jul 2024 | 1,250 | 6,250 | - | - | Restricted Stock Unit | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jul 2024 | 1,145 | 2,290 | - | - | Restricted Stock Unit | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 107.40 per share. | 20 Jul 2024 | 499 | 77,418 (0%) | 0% | 107.4 | 53,592 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jul 2024 | 1,522 | 9,131 | - | - | Restricted Stock Unit | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jul 2024 | 1,774 | 3,550 | - | - | Restricted Stock Unit | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 105.16 per share. | 20 Jul 2024 | 2,638 | 210,377 (0%) | 0% | 105.2 | 277,410 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jul 2024 | 1,774 | 213,015 (0%) | 0% | - | Common Stock | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jul 2024 | 3,386 | 211,241 (0%) | 0% | - | Common Stock | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jul 2024 | 3,386 | 20,316 | - | - | Restricted Stock Unit | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jul 2024 | 856 | 5,136 | - | - | Restricted Stock Unit | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jul 2024 | 644 | 1,288 | - | - | Restricted Stock Unit | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 105.16 per share. | 20 Jul 2024 | 815 | 207,457 (0%) | 0% | 105.2 | 85,704 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jul 2024 | 644 | 208,272 (0%) | 0% | - | Common Stock | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jul 2024 | 856 | 207,628 (0%) | 0% | - | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 108.63 per share. | 01 Jul 2024 | 1,793 | 302,715 (0%) | 0% | 108.6 | 194,781 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 109.33 per share. | 01 Jul 2024 | 907 | 301,808 (0%) | 0% | 109.3 | 99,163 | Common Stock |
| Herm Rosenman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 2,964 | 65,381 (0%) | 0% | - | Common Stock | |
| James I. Healy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 2,964 | 45,674 (0%) | 0% | - | Common Stock | |
| Ruth W. Brinkley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 2,964 | 2,964 (0%) | 0% | - | Common Stock | |
| Roelof Frederik Botha | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 2,964 | 3,330 (0%) | 0% | - | Common Stock | |
| Roy D. Baynes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 2,964 | 15,540 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jun 2024 | 12,500 | 80,042 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jun 2024 | 12,500 | 12,500 | - | - | Restricted Stock Unit | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 108.37 per share. | 28 Jun 2024 | 4,983 | 75,059 (0%) | 0% | 108.4 | 539,987 | Common Stock |
| Gail B. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 2,964 | 21,598 (0%) | 0% | - | Common Stock | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jun 2024 | 37,500 | 250,851 (0%) | 0% | - | Common Stock | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jun 2024 | 37,500 | 37,500 | - | - | Restricted Stock Unit | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 109.43 per share. | 28 Jun 2024 | 2,431 | 213,351 (0%) | 0% | 109.4 | 266,020 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 107.73 per share. | 28 Jun 2024 | 24,008 | 226,843 (0%) | 0% | 107.7 | 2,586,456 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 108.61 per share. | 28 Jun 2024 | 11,061 | 215,782 (0%) | 0% | 108.6 | 1,201,329 | Common Stock |
| Rowan E. Chapman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 2,964 | 7,969 (0%) | 0% | - | Common Stock | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jun 2024 | 5,000 | 209,495 (0%) | 0% | - | Common Stock | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 108.37 per share. | 28 Jun 2024 | 2,723 | 206,772 (0%) | 0% | 108.4 | 295,080 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jun 2024 | 5,000 | 5,000 | - | - | Restricted Stock Unit | |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 109.66 per share. | 18 Jun 2024 | 2,700 | 304,508 (0%) | 0% | 109.7 | 296,080 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 110.35 per share. | 17 Jun 2024 | 1,615 | 217,841 (0%) | 0% | 110.3 | 178,211 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 112.55 per share. | 17 Jun 2024 | 1,247 | 213,351 (0%) | 0% | 112.6 | 140,350 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 111.88 per share. | 17 Jun 2024 | 3,243 | 214,598 (0%) | 0% | 111.9 | 362,811 | Common Stock |
| Gail B. Marcus | Director | Sale of securities on an exchange or to another person at price $ 110.16 per share. | 30 May 2024 | 2,000 | 18,634 (0%) | 0% | 110.2 | 220,330 | Common Stock |
| Rowan E. Chapman | Director | Sale of securities on an exchange or to another person at price $ 109.09 per share. | 28 May 2024 | 4,856 | 5,005 (0%) | 0% | 109.1 | 529,728 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 109.96 per share. | 28 May 2024 | 1,647 | 114,186 (0%) | 0% | 110.0 | 181,103 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 109.96 per share. | 28 May 2024 | 1,438 | 109,940 (0%) | 0% | 110.0 | 158,122 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 107.90 per share. | 23 May 2024 | 344 | 68,738 (0%) | 0% | 107.9 | 37,118 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 107.77 per share. | 23 May 2024 | 264 | 68,818 (0%) | 0% | 107.8 | 28,450 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 108.92 per share. | 23 May 2024 | 236 | 68,582 (0%) | 0% | 108.9 | 25,704 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 109.16 per share. | 23 May 2024 | 156 | 68,582 (0%) | 0% | 109.2 | 17,029 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Gift of securities by or to the insider at price $ 0.00 per share. | 16 May 2024 | 11,853 | 307,208 (0%) | 0% | 0 | Common Stock | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 107.59 per share. | 15 May 2024 | 3,320 | 219,456 (0%) | 0% | 107.6 | 357,201 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 106.59 per share. | 15 May 2024 | 3,459 | 222,776 (0%) | 0% | 106.6 | 368,710 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 106.32 per share. | 10 May 2024 | 611 | 319,151 (0%) | 0% | 106.3 | 64,959 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 103.06 per share. | 10 May 2024 | 349 | 321,412 (0%) | 0% | 103.1 | 35,967 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 104.61 per share. | 10 May 2024 | 990 | 320,422 (0%) | 0% | 104.6 | 103,559 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 105.51 per share. | 10 May 2024 | 660 | 319,762 (0%) | 0% | 105.5 | 69,636 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 107.48 per share. | 10 May 2024 | 90 | 319,061 (0%) | 0% | 107.5 | 9,673 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 101.55 per share. | 10 May 2024 | 5,997 | 228,498 (0%) | 0% | 101.6 | 608,998 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 104.03 per share. | 10 May 2024 | 4,255 | 214,845 (0%) | 0% | 104.0 | 442,634 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 102.91 per share. | 10 May 2024 | 9,398 | 219,100 (0%) | 0% | 102.9 | 967,152 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.68 per share. | 10 May 2024 | 30,000 | 234,495 (0%) | 0% | 19.7 | 590,400 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2024 | 30,000 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 108.09 per share. | 10 May 2024 | 10,350 | 204,495 (0%) | 0% | 108.1 | 1,118,783 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.40 per share. | 08 May 2024 | 215,000 | 1,290,648 (1%) | 0% | 5.4 | 1,159,990 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2024 | 215,000 | 398,496 | - | - | Stock Option (right to buy) | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 94.70 per share. | 01 May 2024 | 400 | 67,742 (0%) | 0% | 94.7 | 37,879 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 93.88 per share. | 01 May 2024 | 866 | 68,142 (0%) | 0% | 93.9 | 81,299 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 92.60 per share. | 01 May 2024 | 400 | 69,008 (0%) | 0% | 92.6 | 37,038 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 95.64 per share. | 01 May 2024 | 200 | 67,542 (0%) | 0% | 95.6 | 19,128 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 93.14 per share. | 29 Apr 2024 | 1,238 | 69,408 (0%) | 0% | 93.1 | 115,306 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 93.14 per share. | 29 Apr 2024 | 4,084 | 226,235 (0%) | 0% | 93.1 | 380,378 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 93.14 per share. | 29 Apr 2024 | 1,057 | 204,495 (0%) | 0% | 93.1 | 98,448 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 93.14 per share. | 29 Apr 2024 | 1,196 | 115,833 (0%) | 0% | 93.1 | 111,394 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 93.14 per share. | 29 Apr 2024 | 929 | 110,748 (0%) | 0% | 93.1 | 86,526 | Common Stock |
| Herm Rosenman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2024 | 488 | 62,173 (0%) | 0% | - | Common Stock | |
| Herm Rosenman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2024 | 244 | 62,417 (0%) | 0% | - | Common Stock | |
| James I. Healy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2024 | 210 | 42,710 (0%) | 0% | - | Common Stock | |
| Roelof Frederik Botha | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2024 | 278 | 21,042 (0%) | 0% | - | Common Stock | |
| Roelof Frederik Botha | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2024 | 488 | 20,764 (0%) | 0% | - | Common Stock | |
| Roy D. Baynes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2024 | 169 | 12,576 (0%) | 0% | - | Common Stock | |
| Gail B. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2024 | 488 | 20,634 (0%) | 0% | - | Common Stock | |
| Rowan E. Chapman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2024 | 488 | 9,861 (0%) | 0% | - | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 89.55 per share. | 25 Apr 2024 | 500 | 69,082 (0%) | 0% | 89.6 | 44,775 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 89.55 per share. | 25 Apr 2024 | 500 | 69,082 (0%) | 0% | 89.6 | 44,775 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 92.00 per share. | 24 Apr 2024 | 751 | 70,646 (0%) | 0% | 92 | 69,092 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 89.55 per share. | 24 Apr 2024 | 705 | 71,397 (0%) | 0% | 89.6 | 63,133 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 93.00 per share. | 24 Apr 2024 | 937 | 72,102 (0%) | 0% | 93.0 | 87,140 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 91.38 per share. | 23 Apr 2024 | 531 | 117,029 (0%) | 0% | 91.4 | 48,522 | Common Stock |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 91.38 per share. | 23 Apr 2024 | 522 | 111,677 (0%) | 0% | 91.4 | 47,700 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Apr 2024 | 143 | 430 | - | - | Restricted Stock Unit | |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Apr 2024 | 190 | 1,332 | - | - | Restricted Stock Unit | |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Apr 2024 | 143 | 321,364 (0%) | 0% | - | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Apr 2024 | 190 | 321,221 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Apr 2024 | 1,521 | 72,167 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Apr 2024 | 1,250 | 7,500 | - | - | Restricted Stock Unit | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Apr 2024 | 1,145 | 3,435 | - | - | Restricted Stock Unit | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Apr 2024 | 1,521 | 10,653 | - | - | Restricted Stock Unit | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 91.38 per share. | 20 Apr 2024 | 1,523 | 73,039 (0%) | 0% | 91.4 | 139,171 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Apr 2024 | 1,250 | 74,562 (0%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Apr 2024 | 1,145 | 73,312 (0%) | 0% | - | Common Stock | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Apr 2024 | 3,386 | 231,096 (0%) | 0% | - | Common Stock | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Apr 2024 | 1,775 | 232,871 (0%) | 0% | - | Common Stock | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 91.38 per share. | 20 Apr 2024 | 2,552 | 230,319 (0%) | 0% | 91.4 | 233,200 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Apr 2024 | 3,386 | 23,702 | - | - | Restricted Stock Unit | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Apr 2024 | 1,775 | 5,324 | - | - | Restricted Stock Unit | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Apr 2024 | 644 | 1,932 | - | - | Restricted Stock Unit | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Apr 2024 | 856 | 5,992 | - | - | Restricted Stock Unit | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 91.38 per share. | 20 Apr 2024 | 787 | 205,552 (0%) | 0% | 91.4 | 71,915 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Apr 2024 | 644 | 206,339 (0%) | 0% | - | Common Stock | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Apr 2024 | 856 | 205,695 (0%) | 0% | - | Common Stock | |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 91.06 per share. | 16 Apr 2024 | 53,489 | 117,560 (0%) | 0% | 91.1 | 4,870,730 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 90.34 per share. | 16 Apr 2024 | 26,511 | 171,049 (0%) | 0% | 90.3 | 2,394,922 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 93.91 per share. | 15 Apr 2024 | 2,411 | 227,810 (0%) | 0% | 93.9 | 226,417 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 92.67 per share. | 15 Apr 2024 | 4,305 | 230,221 (0%) | 0% | 92.7 | 398,937 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 94.44 per share. | 15 Apr 2024 | 100 | 227,710 (0%) | 0% | 94.4 | 9,444 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 93.37 per share. | 03 Apr 2024 | 7,863 | 321,031 (0%) | 0% | 93.4 | 734,140 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 92.57 per share. | 03 Apr 2024 | 10,138 | 328,894 (0%) | 0% | 92.6 | 938,478 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 91.53 per share. | 03 Apr 2024 | 8,699 | 339,032 (0%) | 0% | 91.5 | 796,204 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 92.62 per share. | 02 Apr 2024 | 1,378 | 70,646 (0%) | 0% | 92.6 | 127,629 | Common Stock |
| Roelof Frederik Botha | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 67.37 per share. | 15 Mar 2024 | 424 | 776 (0%) | 0% | 67.4 | 28,565 | Common Stock |
| Roelof Frederik Botha | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 607 | 0 | - | - | Stock Option (right to buy) | |
| Roelof Frederik Botha | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 687 | 0 | - | - | Stock Option (right to buy) | |
| Roelof Frederik Botha | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 807 | 0 | - | - | Stock Option (right to buy) | |
| Roelof Frederik Botha | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 793 | 0 | - | - | Stock Option (right to buy) | |
| Roelof Frederik Botha | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 851 | 0 | - | - | Stock Option (right to buy) | |
| Roelof Frederik Botha | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 884 | 0 | - | - | Stock Option (right to buy) | |
| Roelof Frederik Botha | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 14,136 | 0 | - | - | Stock Option (right to buy) | |
| Roelof Frederik Botha | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 735 | 0 | - | - | Stock Option (right to buy) | |
| Roelof Frederik Botha | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 424 | 0 | - | - | Stock Option (right to buy) | |
| Roelof Frederik Botha | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.26 per share. | 15 Mar 2024 | 807 | 20,276 (0%) | 0% | 38.3 | 30,876 | Common Stock |
| Roelof Frederik Botha | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.88 per share. | 15 Mar 2024 | 687 | 19,469 (0%) | 0% | 45.9 | 31,520 | Common Stock |
| Roelof Frederik Botha | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 51.40 per share. | 15 Mar 2024 | 607 | 18,782 (0%) | 0% | 51.4 | 31,200 | Common Stock |
| Roelof Frederik Botha | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 41.82 per share. | 15 Mar 2024 | 793 | 18,175 (0%) | 0% | 41.8 | 33,163 | Common Stock |
| Roelof Frederik Botha | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 41.51 per share. | 15 Mar 2024 | 851 | 17,382 (0%) | 0% | 41.5 | 35,325 | Common Stock |
| Roelof Frederik Botha | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.48 per share. | 15 Mar 2024 | 884 | 16,531 (0%) | 0% | 40.5 | 35,784 | Common Stock |
| Roelof Frederik Botha | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 41.19 per share. | 15 Mar 2024 | 14,136 | 15,647 (0%) | 0% | 41.2 | 582,262 | Common Stock |
| Roelof Frederik Botha | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.86 per share. | 15 Mar 2024 | 735 | 1,511 (0%) | 0% | 42.9 | 31,502 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.27 per share. | 15 Mar 2024 | 27,655 | 296,477 (0%) | 0% | 20.3 | 560,567 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 18,750 | 0 | - | - | Stock Option (right to buy) | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 27,655 | 3,595 | - | - | Stock Option (right to buy) | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 21,865 | 2,084 | - | - | Stock Option (right to buy) | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 89.63 per share. | 15 Mar 2024 | 28,334 | 232,004 (0%) | 0% | 89.6 | 2,539,599 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 88.98 per share. | 15 Mar 2024 | 34,960 | 260,338 (0%) | 0% | 89.0 | 3,110,884 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 87.96 per share. | 15 Mar 2024 | 19,929 | 295,298 (0%) | 0% | 88.0 | 1,753,050 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.46 per share. | 15 Mar 2024 | 18,750 | 315,227 (0%) | 0% | 25.5 | 477,375 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.01 per share. | 15 Mar 2024 | 21,865 | 268,822 (0%) | 0% | 13.0 | 284,464 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Mar 2024 | 55,427 | 70,082 (0%) | 0% | 0 | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Mar 2024 | 55,427 | 70,082 (0%) | 0% | 0 | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Mar 2024 | 110,854 | 347,731 (0%) | 0% | 0 | Common Stock | |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 87.25 per share. | 05 Mar 2024 | 8 | 1,076,652 (1%) | 0% | 87.3 | 698 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 89.40 per share. | 05 Mar 2024 | 5,492 | 860,036 (1%) | 0% | 89.4 | 491,004 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 88.64 per share. | 05 Mar 2024 | 13,743 | 865,528 (1%) | 0% | 88.6 | 1,218,237 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 87.49 per share. | 05 Mar 2024 | 96,977 | 879,271 (1%) | 0% | 87.5 | 8,484,964 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 86.88 per share. | 05 Mar 2024 | 73,788 | 976,248 (1%) | 0% | 86.9 | 6,410,864 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 88.36 per share. | 05 Mar 2024 | 1,004 | 1,075,648 (1%) | 0% | 88.4 | 88,718 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 88.36 per share. | 05 Mar 2024 | 1,028 | 463,585 (0%) | 0% | 88.4 | 90,839 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 88.45 per share. | 05 Mar 2024 | 3,184 | 460,401 (0%) | 0% | 88.5 | 281,635 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 89.13 per share. | 05 Mar 2024 | 1,816 | 458,585 (0%) | 0% | 89.1 | 161,857 | Common Stock |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 88.36 per share. | 05 Mar 2024 | 2,826 | 70,646 (0%) | 0% | 88.4 | 249,719 | Common Stock |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 88.37 per share. | 05 Mar 2024 | 9,326 | 246,957 (0%) | 0% | 88.4 | 824,092 | Common Stock |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 88.36 per share. | 05 Mar 2024 | 2,160 | 204,218 (0%) | 0% | 88.4 | 190,868 | Common Stock |
| Matthew Rabinowitz | Director, EXECUTIVE CHAIRMAN | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 4,104 | 1,076,660 (1%) | 0% | - | Common Stock | |
| Michael Brophy | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 2,826 | 73,472 (0%) | 0% | - | Common Stock | |
| Steven Leonard Chapman | Director, CEO AND PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 9,326 | 256,283 (0%) | 0% | - | Common Stock | |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 2,160 | 206,378 (0%) | 0% | - | Common Stock | |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 2,329 | 197,306 (0%) | 0% | - | Common Stock | |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 2,400 | 110,894 (0%) | 0% | - | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 86.63 per share. | 29 Feb 2024 | 4,933 | 464,686 (0%) | 0% | 86.6 | 427,352 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 85.47 per share. | 29 Feb 2024 | 3,966 | 469,619 (0%) | 0% | 85.5 | 338,956 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 89.27 per share. | 29 Feb 2024 | 400 | 463,585 (0%) | 0% | 89.3 | 35,708 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 90.02 per share. | 29 Feb 2024 | 3,000 | 14,655 (0%) | 0% | 90.0 | 270,073 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Feb 2024 | 1,028 | 464,613 (0%) | 0% | - | Common Stock | |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 90.01 per share. | 29 Feb 2024 | 3,000 | 14,655 (0%) | 0% | 90.0 | 270,036 | Common Stock |
| Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 87.61 per share. | 29 Feb 2024 | 701 | 463,985 (0%) | 0% | 87.6 | 61,417 | Common Stock |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Feb 2024 | 3,206 | 200,512 (0%) | 0% | - | Common Stock |